Etienne Mathier
Papers
1
Total Citations
3
H-Index
1
About
Etienne Mathier is a radiation oncologist whose research centers on optimizing stereotactic body radiotherapy (SBRT) for prostate cancer, with a particular focus on fractionation schedules and treatment toxicity. His most cited work, a 2023 propensity score matched pair analysis comparing five versus seven fractions of SBRT for intermediate- and high-risk prostate cancer, directly addresses a critical clinical question: how to maximize tumor control while minimizing side effects. By retrospectively analyzing data from 198 patients across two institutions, Mathier provided real-world evidence that shorter, five-fraction regimens may offer comparable efficacy with potentially reduced toxicity, a finding that has immediate implications for clinical practice and patient quality of life. Though early in his career, his work has already garnered attention, accumulating citations that underscore its relevance to the ongoing refinement of prostate cancer radiotherapy. Mathier’s research sits at the intersection of precision medicine and patient-centered care, contributing to the broader effort to tailor SBRT schedules to individual risk profiles. His collaborative, multi-institutional approach and focus on clinically meaningful endpoints mark him as a rising voice in radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1